CAMPBELL, Calif., Oct. 10, 2018 — VIVUS, Inc. (Nasdaq: VVUS) (the “Company”), a specialty pharmaceutical company committed to the development and commercialization of innovative therapies focusing on treatments for patients with serious unmet medical needs, today announced that John Amos, Chief Executive Officer, will present at the BIO Investor Forum on Wednesday, October 17, 2018 at 11:15am PT/2:15pm ET in San Francisco. Mr. Amos will provide a corporate overview, review the Company’s clinical and commercial product portfolio, and discuss the company’s strategies for building a portfolio of cash flow-positive assets, reducing its debt and moving toward sustained profitability.
An audio webcast of the presentation will be available in the events and presentations section of the Company’s investor relations website, or by clicking here.
VIVUS is a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs. For more information about the Company, please visit www.vivus.com.